News, reviews and podcasts from annual scientific meetings and symposiums around the world.
Over the past decade, the approval of immune checkpoint inhibitors has revolutionised treatment for patients…
Adding the targeted therapy drug ribociclib to hormonal (endocrine) therapy showed a significant improvement in…
Adding the immunotherapy drug pembrolizumab to chemotherapy, with or without bevacizumab, improved overall survival (OS) and…
Five-year overall survival improved by 30% for children with acute lymphoblastic leukaemia (ALL) who were…
Women with obesity when they are diagnosed with early breast cancer have a higher risk…
ESMO, the leading professional organisation for medical oncology, today announced the launch of a new…
Australia is riding a wave of emerging innovative and ground-breaking diagnostic technologies and cancer treatments…
Victoria Sharp had survived two bouts of breast cancer, melanoma and ovarian cancer when she…
Close to 90 percent of patients with unresectable (inoperable) desmoplastic melanoma, a rare form of…
The NCCN 2023 Annual Conference took place in-person in Orlando and virtually, with a particular…